Business
ASX 200 rises 0.5%, Mesoblast plunges – Motley Fool Australia
The S&P/ASX 200 Index (ASX:XJO) went up 0.5% today, with the Mesoblast Limited (ASX:MSB) share price plunging 30.6% on FDA news.
The S&P/ASX 200 Index (ASX: XJO) rose by almost 0.5% today with the ASX continuing to climb.
There was one major plunge on the ASX:
Mesoblast Limited (ASX: MSB) share price crashes lower by 30.6%
Mesoblast released an announcement today on the scheduled meeting of the Oncologic Drugs Advisory Committee (ODAC) of the US FDA for the approval of Ryoncil in the treatment of steroid-refractory acute graft versus host disease in children.
The meeting is scheduled to take place on 13 August 202…
-
General10 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Business19 hours agoBell Potter names the best ASX shares to buy in October
-
Noosa News22 hours agoResilience features in Sunshine Coast Open House
-
Noosa News17 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025